Search
for
Sort by
Research 61–90 of 416
- Severe cutaneous adverse reactions to drugs
- Acute liver damage due to <i>Serenoa repens</i>: a case report
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Post-Exposure Syndromes as State-Space Trapping: A set-theoretic perspective on PSSD and the post-exposure family.
- Post-Exposure Syndromes as State-Space Trapping: A set-theoretic perspective on PSSD and the post-exposure family.
- KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning
- Community Detection and Patient Experience Analysis in Reddit Conversations on Janus Kinase Inhibitors using Large Language Models
- Failing Public Health Again? Analytical Review of Depression and Suicidality From Finasteride
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Comparison of the pharmacoeconomic profiles of treatment regimens for field pattern actinic keratoses
- The Danish Health and Medicines Authority has issued a warning that split and crushed finasteride tablets may pose a risk to pregnant and fertile women.
- Hair loss in the era of CGRP inhibition: emerging evidence, mechanisms, and clinical implications
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- Supplementary Material for: Finasteride and Suicide: A Postmarketing Case Series
- Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Medical Technologies: Pharmaceutical Cosmetology, Cosmeceuticals – Opportunities and Limitations
- Amitriptyline-induced Telogen Effluvium in a Patient with Cervical Disc Prolapse: A Case Report
- A Prospective Observational Study for Assessment of Chemotherapy-Induced Adverse Drug Reactions in Cancer Patients
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Young patients using finasteride exhibit risk of suicidality
- Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Hypertrichosis as a side effect of inhaled steroids in children